DOCSLIB.ORG

Current P SYCHIATRY

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Current P SYCHIATRY Current p SYCHIATRY How to prevent hyperprolactinemia in patients taking antipsychotics Atypical antipsychotics elevate serum prolactin levels at least transiently, and this effect depends on each compound’s dopamine-binding properties. W. Victor R. Vieweg, MD ntipsychotics have long been linked with hyperpro- 1 Professor of psychiatry and internal medicine lactinemia. This phenomenon was first considered Medical College of Virginia A a drug class effect, but the arrival of clozapine, bet- Virginia Commonwealth University, Richmond ter deliniation of dopamine receptor subtypes, and identifica- Antony Fernandez, MD tion of the four principal CNS dopamine pathways revealed that hyperprolactinemia was not a universal consequence of Assistant clinical professor of psychiatry Medical College of Virginia antipsychotic use. Virginia Commonwealth University We now know that most atypical antipsychotics are less Psychiatry Service McGuire VA Medical Center, Richmond likely to induce hyperprolactinemia than older antipsy- chotics, but we don’t know why. The most likely explanation is that most of the newer agents block dopamine D2 mini- mally in the hypothalamic tuberoinfundibular pathway.2 Evidence is emerging that atypical agents elevate serum pro- lactin levels at least transiently—but usually less than typical antipsychotics—and this effect varies, depending on each compound’s dopamine-binding properties. continued on page 58 VOL. 2, NO. 2 / FEBRUARY 2003 57 Hyperprolactinemia Figure 1 CHANGES IN PROLACTIN LEVELS OVER TIME Reproductive period post-reproductive 200 Breast feeding 100 Mean serum prolactin concentrations Peak 30 minutes from puberty until menopause. after suckling For nursing women, the length of the arrows depicts the increase in serum Non-lactating prolactin concentration associated with 20 each episode of suckling. The Y-axis expresses serum prolactin concentration 10 Prolactin (ng/ml or mg/l) in both ng/ml and mg/l. 5 Pregnancy Puerperium Source: Adapted and reprinted with permission from Friesen HG. Human prolactin. Ann R Coll Phys Surg Female Can 1978;11:275-81. Male 12 50 60 Age (years) Prolactin physiology ing in higher prolactin levels in premenopausal women than Prolactin—a large peptide containing 198 amino acids—was in men. the first anterior pituitary gland hormone to be isolated in pure form.3 Despite its molecular weight of approximately Prolactin secretion 23,000, the hormone easily crosses the blood-brain barrier.4 Normally, prolactin is secreted in pulses—approximately 14 Similar to other anterior in a 24-hour period, with an interpulse interval of about 80 pituitary hormones, prolactin is minutes.5 A bimodal daily pattern of secre- secreted episodically. Its secretion is tion is superimposed upon this pattern, with inhibited by dopamine release from the The hypothalamus peak levels at night and trough levels at hypothalamus and enhanced by different noon. Stress—including surgery and gener- prolactin-releasing factors. Prolactin is the blunts prolactin al anesthesia, exercise, and hypoglycemia— only anterior pituitary hormone that is pro- secretion primarily via may transiently increase prolactin levels. duced by tuberoinfundibular neurons governed dopamine release Endocrine regulation. Estrogen modulates by dopamine.5 Dopamine stimulates lactotrope the response of hypothalamic factors that D2 receptors and inhibits adenylate cyclase, control prolactin production. It stimulates resulting in reduced prolactin synthesis and decreased prolactin response to dopamine and release. increased response to thyrotropic-releasing hormone. Serum prolactin concentrations change Insulin also stimulates prolactin secretion—probably by during various life stages (Figure 1).6 Estrogen’s effects on inducing hypoglycemia. Serum insulin level changes within prolactin gene expression regulate prolactin synthesis, result- physiologic ranges appear to affect prolactin regulation. 58 Current VOL. 2, NO. 2 / FEBRUARY 2003 p SYCHIATRY Current p SYCHIATRY Neuroendocrine regulation. The hypothalamus Table 1 blunts prolactin secretion primarily via COMMON CLINICAL EFFECTS IN PATIENTS dopamine release. This modulation occurs prin- WITH HYPERPROLACTINEMIA cipally within the tuberoinfundibular dopamine pathway. The D2 subtype is the only dopamine Organ or syndrome Clinical effects receptor in the anterior pituitary gland: • a decrease in dopamine levels reaching the Behavior Direct effects anterior pituitary gland increases the num- Secondary effects due to ber of D2 receptors hypogonadism • to a lesser extent, estrogen decreases the Possible cognitive impairment number of D2 receptors. Bones Decreased bone mineral density due Dopamine-modulated reductions in action to testosterone or estrogen deficits potential discharge from lactotrophs and in cal- cium flux leads to decreased intracellular calci- Breast Engorgement um and decreased prolactin secretion.5 Lactation unrelated to breast feeding Most hormones are target-organ agents and are regulated via a feedback loop that includes Cardiovascular system Possible adverse effects due to low the peripheral circulation. Prolactin, however, is levels of testosterone or estrogen not considered to have a specific target organ. It Menstrual function Absence of ovulation is its own inhibiting factor, using an autoregula- Amenorrhea tory, pituitary-to-hypothalamus short-loop feed- back circuit. Sexual function Reduced libido For example, prolactin-secreting tumors or Reduced arousal drugs that elevate hormone levels lead to an Orgasmic dysfunction increase in dopamine. In contrast, hypophysec- tomy decreases dopamine. In this setting, pro- Source: Adapted and reprinted with permission from Dickson RA, Glazer WM. Neuroleptic- induced hyperprolactinemia. Schizophr Res 1999;35(suppl):S75-S86. lactin injections will restore normal dopamine levels. Prolactin-releasing factors include thy- rotropic-releasing hormone, vasoactive intestinal peptide, Diagnosis of hyperprolactinemia and serotonin. Pathologic hyperprolactinemia is defined as consistently ele- vated serum prolactin concentration (>20 ng/ml) in the Prolactin’s actions absence of pregnancy or postpartum lactation. Because of the Many tissues—including breast, liver, ovary, testis, and pulsatile nature of prolactin secretion, a definitive diagnosis prostate—have prolactin receptors. These receptors are stim- of hyperprolactinemia requires three serum prolactin levels ulated with equal potency by prolactin and growth hormone. taken on different mornings. The principal site of prolactin action is the mammary Clinical presentation. Hyperprolactinemia—the most com- gland, where the hormone initiates and maintains lactation mon hypothalamic-pituitary disturbance—usually presents after childbirth. Major stimuli for breast development are with clinical features of gonadal dysfunction (Table 1).8 estrogen, progesterone, prolactin, and placental mammotrop- Symptoms and signs related to a brain mass—headache, ic hormones. Other stimuli include insulin, cortisol, and thy- visual field disturbances, ophthalmoplegia, and reduced visu- roid hormone.7 al acuity—may predominate with a large pituitary tumor. Gonadotropin secretion is influenced by prolactin via The patient may first present to a primary care physician or the hypothalamus. Prolactin-mediated inhibition of luteiniz- to a clinical specialist, such as a gynecologist, neurologist, ing hormone-releasing hormone secretion impairs ophthalmologist, pediatrician, psychiatrist, or urologist. gonadotropin release and inhibits gonadal function. Thirty to 80% of women with hyperprolactinemia devel- VOL. 2, NO. 2 / FEBRUARY 2003 59 Hyperprolactinemia op galactorrhea,9 although some women with galactorrhea have long-term effects on bone density. Trabecular bone mass have normal prolactin levels. Men with hyperprolactinemia has been found to be reduced in young women with amenor- usually have gonadal dysfunction, which unfortunately is rhea secondary to hyperprolactinemia. This trabecular often attributed to “psychogenic” causes. Particularly in men, osteopenia is reversible—spinal bone density decreases pro- prolactin is implicated in the control of libido. gressively without treatment and improves when hyperpro- Causes. Hyperprolactinemia may be caused by any process lactinemia is treated. Menstrual function appears to best pre- that inhibits dopamine synthesis, the neurotransmitter’s dict risk of progressive spinal osteopenia in women with transport to the anterior pituitary gland, or its action at the hyperprolactinemia. Estradiol level is a stronger predictor of lactotrope dopamine receptors (Table 2).9 In this article, we clinical course than is the prolactin level.10 will limit our discussion to antipsychotic drugs. Estrogen and prolactin. During pregnancy, the rise in estro- Antipsychotic drugs and hyperprolactinemia gen levels probably stimulates an increase in prolactin. Among the four principal dopamine pathways in the brain, Increased prolactin levels are also found in women taking the tuberoinfundibular pathway is a system of short axons at the base of the hypothalamus that Table 2 releases dopamine into the portal CAUSES OF PATHOLOGIC HYPERPROLACTINEMIA veins of the pituitary gland. Terminals in the median eminence Hypothalamic disease Tumor, infiltrative disease, pseudotumor of the hypothalamus release cerebri, cranial radiation dopamine that travels down the pituitary stalk in the portal veins. Pituitary disease Prolactinoma, acromegaly, Cushing’s Typical antipsychotics block disease,
Load more

Recommended publications
  • Leptin Stimulates Pituitary Prolactin Release Through an Extracellular Signal-Regulated Kinase-Dependent Pathway
    275 Leptin stimulates pituitary prolactin release through an extracellular signal-regulated kinase-dependent pathway Christian K Tipsmark, Christina N Strom, Sean T Bailey and Russell J Borski Department of Zoology, North Carolina State University, Raleigh, North Carolina 27695-7617, USA (Correspondence should be addressed to C K Tipsmark who is now at Institute of Biology, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark; Email: [email protected]) Abstract Leptin was initially identified as a regulator of appetite and leptin are mediated by the activation of extracellular signal- weight control centers in the hypothalamus, but appears to be regulated kinase (ERK1/2) but nothing is known about the involved in a number of physiological processes. This study cellular mechanisms by which leptin might regulate PRL was carried out to examine the possible role of leptin in secretion in vertebrates. We therefore tested whether regulating prolactin (PRL) release using the teleost pituitary ERK1/2 might be involved in the leptin PRL response and model system. This advantageous system allows isolation of a found that the ERK inhibitor, PD98059, hindered leptin- nearly pure population of lactotropes in their natural, in situ induced PRL release. We further analyzed leptin response by aggregated state. The rostral pars distalis were dissected from quantifying tyrosine and threonine phosphorylation of tilapia pituitaries and exposed to varying concentrations of ERK1/2 using western blots. One hour incubation with leptin (0, 1, 10, 100 nM) for 1 h. Release of PRL was leptin induced a concentration-dependent increase in stimulated by leptin in a potent and concentration-dependent phosphorylated, and thus active, ERK1/2.
    [Show full text]
  • Download/Rozdzial05.Pdf (Accessed on 1 January 2007)
    cancers Article Early Alcohol Use Initiation, Obesity, Not Breastfeeding, and Residence in a Rural Area as Risk Factors for Breast Cancer: A Case-Control Study Dorota Anna Dydjow-Bendek * and Paweł Zagozd˙ zon˙ Department of Hygiene and Epidemiology, Medical University of Gdansk, 80-211 Gdansk, Poland; [email protected] * Correspondence: [email protected] Simple Summary: Breast cancer became the most common cancer globally in 2021, according to the World Health Organization. The aim of the study was to evaluate risk factors for breast cancer, such as early alcohol use initiation, obesity, breastfeeding, and place of residence. The effect of alcohol consumption by girls has been assessed in only a few studies and is not fully understood. In this study, it has been found to be associated with a higher risk of breast cancer. Our study also shed light on the incidence disparity—women were more at risk in the countryside than in the city. The results of this study should be included in the preparation of breast cancer prevention programs and also aimed at women in adolescence and early adulthood because exposures during childhood and adolescence can affect a woman’s long-term risk of breast cancer. Every effort should also be made to ensure that access to knowledge is open to all, regardless of where they live, giving all women equal opportunities. Citation: Dydjow-Bendek, D.A.; Zagozd˙ zon,˙ P. Early Alcohol Use Abstract: Initiation, Obesity, Not Breastfeeding, The aim of this study was to determine the risk factors for breast cancer in the Polish and Residence in a Rural Area as Risk population.
    [Show full text]
  • Substance Use in Pregnancy
    MAY 2017 SUBSTANCE USE IN PREGNANCY Prepared By: Aaron Fields, MD University of Rochester Medical Center, NYS Maternal & Infant Health Center of Excellence 265 Crittenden Blvd, Rochester, NY 14642 – Tel: 585-276-7893 – Fax: 585-461-4532 [email protected] – www.mihcoe.org Introduction ..............................................................................................................................................................2 What is Addiction? .....................................................................................................................................................3 Drugs of Abuse ..........................................................................................................................................................4 Opioids ................................................................................................................................................................................ 4 Stimulants ........................................................................................................................................................................... 4 Nicotine............................................................................................................................................................................... 5 Alcohol ................................................................................................................................................................................ 6 Marijuana ...........................................................................................................................................................................
    [Show full text]
  • Anatomy of the Human Mammary Gland: Current Status of Knowledge
    Clinical Anatomy 00:000–000 (2012) REVIEW Anatomy of the Human Mammary Gland: Current Status of Knowledge 1,2 1 FOTEINI HASSIOTOU AND DONNA GEDDES * 1Hartmann Human Lactation Research Group, School of Chemistry and Biochemistry, Faculty of Science, The University of Western Australia, Crawley, Western Australia, Australia 2School of Anatomy, Physiology and Human Biology, Faculty of Science, The University of Western Australia, Crawley, Western Australia, Australia Mammary glands are unique to mammals, with the specific function of synthe- sizing, secreting, and delivering milk to the newborn. Given this function, it is only during a pregnancy/lactation cycle that the gland reaches a mature devel- opmental state via hormonal influences at the cellular level that effect drastic modifications in the micro- and macro-anatomy of the gland, resulting in remodeling of the gland into a milk-secretory organ. Pubertal and post-puber- tal development of the breast in females aids in preparing it to assume a func- tional state during pregnancy and lactation. Remarkably, this organ has the capacity to regress to a resting state upon cessation of lactation, and then undergo the same cycle of expansion and regression again in subsequent pregnancies during reproductive life. This plasticity suggests tight hormonal regulation, which is paramount for the normal function of the gland. This review presents the current status of knowledge of the normal macro- and micro-anatomy of the human mammary gland and the distinct changes it undergoes during the key developmental stages that characterize it, from em- bryonic life through to post-menopausal age. In addition, it discusses recent advances in our understanding of the normal function of the breast during lac- tation, with special reference to breastmilk, its composition, and how it can be utilized as a tool to advance knowledge on normal and aberrant breast devel- opment and function.
    [Show full text]
  • Rfamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential
    Pharmaceuticals 2011, 4, 1248-1280; doi:10.3390/ph4091248 OPEN ACCESS Pharmaceuticals ISSN 1424-8247 www.mdpi.com/journal/pharmaceuticals Review RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential Maria Findeisen †, Daniel Rathmann † and Annette G. Beck-Sickinger * Institute of Biochemistry, Leipzig University, Brüderstraße 34, 04103 Leipzig, Germany; E-Mails: [email protected] (M.F.); [email protected] (D.R.) † These authors contributed equally to this work. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +49-341-9736900; Fax: +49-341-9736909. Received: 29 August 2011; in revised form: 9 September 2011 / Accepted: 15 September 2011 / Published: 21 September 2011 Abstract: Different neuropeptides, all containing a common carboxy-terminal RFamide sequence, have been characterized as ligands of the RFamide peptide receptor family. Currently, five subgroups have been characterized with respect to their N-terminal sequence and hence cover a wide pattern of biological functions, like important neuroendocrine, behavioral, sensory and automatic functions. The RFamide peptide receptor family represents a multiligand/multireceptor system, as many ligands are recognized by several GPCR subtypes within one family. Multireceptor systems are often susceptible to cross-reactions, as their numerous ligands are frequently closely related. In this review we focus on recent results in the field of structure-activity studies as well as mutational exploration of crucial positions within this GPCR system. The review summarizes the reported peptide analogs and recently developed small molecule ligands (agonists and antagonists) to highlight the current understanding of the pharmacophoric elements, required for affinity and activity at the receptor family.
    [Show full text]
  • The Milk Supply Equation
    The Making of a Milk Factory Objectives . List the major factors necessary for good milk production . Describe the role of the placenta in mammary gland development during pregnancy. Explain two ways that environmental The Making of a Milk Factory contaminants may interfere with reproductive hormones © 2019 Lisa Marasco MA, IBCLC, FILCA Hormones and Receptors The Milk Supply Equation SUFFICIENT GLANDULAR TISSUE + INTACT NERVE PATHWAYS & DUCTS + ADEQUATE HORMONES & RECEPTORS + ADEQUATE LACTATION-CRITICAL NUTRIENTS + ADEQUATE & EFFECTIVE MILK REMOVAL (Good management, effective baby) = GOOD MILK SUPPLY Directors of the process Important players by stage Hormones important to milk production Puberty Pregnancy Lactation Insulin Estrogen Estrogen Cortisol Lactogenic Progesterone Progesterone Complex HPL Prolactin Chorionic Gonadotropin Maintains metabolism; Growth Hormone Growth Hormone Thyroxine - Supports & directs IGF-1 IGF-1 PTPRF pituitary Prolactin Prolactin Insulin Insulin Regulate mammary blood Cortisol Cortisol PTHrP - flow; calcium transport and Thyroxine Thyroxine homeostasis PTHrP PTHrP Oxytocin Oxytocin - milk delivery With permission: Andaluz Waterbirth Center © Lisa Marasco 2019 1 The Making of a Milk Factory Hormone receptors 101 Hormone Receptors 201 Hormones- travel thru blood or synthesized locally Dynamic: Expressed by genes ER α, β Expressed PR α, β R Up & down regulation where and PRLR L, S Can be resistant as needed OTR H Can be hypersensitive Can be influenced positively or negatively by other hormones Receptors: Integral to hormone function, located on “target tissues,” on or in cells Can be influenced by environment The Big Construction Picture PR-A Phase I ER PR-B ERα Series of stages of organo-genesis lasting until ERβ PRLrL adulthood that are irreversible (fetal through puberty) PR-B Phase II Series of changes involving growth and secretory differentiation of the lobulo-alveolar system that are reversible Estrogen Prolactin Progesterone (Preg, lactation, involution) Horseman, N.
    [Show full text]
  • Co-Regulation of Hormone Receptors, Neuropeptides, and Steroidogenic Enzymes 2 Across the Vertebrate Social Behavior Network 3 4 Brent M
    bioRxiv preprint doi: https://doi.org/10.1101/435024; this version posted October 4, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Co-regulation of hormone receptors, neuropeptides, and steroidogenic enzymes 2 across the vertebrate social behavior network 3 4 Brent M. Horton1, T. Brandt Ryder2, Ignacio T. Moore3, Christopher N. 5 Balakrishnan4,* 6 1Millersville University, Department of Biology 7 2Smithsonian Conservation Biology Institute, Migratory Bird Center 8 3Virginia Tech, Department of Biological Sciences 9 4East Carolina University, Department of Biology 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 bioRxiv preprint doi: https://doi.org/10.1101/435024; this version posted October 4, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Running Title: Gene expression in the social behavior network 2 Keywords: dominance, systems biology, songbird, territoriality, genome 3 Corresponding Author: 4 Christopher Balakrishnan 5 East Carolina University 6 Department of Biology 7 Howell Science Complex 8 Greenville, NC, USA 27858 9 [email protected] 10 2 bioRxiv preprint doi: https://doi.org/10.1101/435024; this version posted October 4, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • The Tanner Stages
    Vermont Department of Health Health Screening Recommendations for Children & Adolescents The Tanner Stages Because the onset and progression of puberty are so variable, Tanner has proposed a scale, now uniformly accepted, to describe the onset and progression of pubertal changes (Fig. 9- I Preadolescent 24). Boys and girls are rated on a 5 point scale. Boys are rated for genital development and no sexual hair pubic hair growth, and girls are rated for breast development and pubic hair growth. Pubic hair growth in females is staged as follows (Fig 9-24, B): II Sparse, pigmented, long, straight, • Stage I (Preadolescent) - Vellos hair develops over the pubes in a manner not greater than that over mainly along labia the anterior wall. There is no sexual hair. and at base of penis • Stage II - Sparse, long, pigmented, downy hair, which is straight or only slightly curled, appears. These hairs are seen mainly along the labia. This stage is difficult to quantitate on black and white photographs, particularly when pictures are of fair-haired subjects. III • Stage III - Considerably darker, coarser, and curlier sexual hair appears. The hair has now spread Darker, coarser, curlier sparsely over the junction of the pubes. • Stage IV - The hair distribution is adult in type but decreased in total quantity. There is no spread to the medial surface of the thighs. • Stage V - Hair is adult in quantity and type and appears to have an inverse triangle of the classically IV Adult, but feminine type. There is spread to the medial surface of the thighs but not above the base of the decreased inverse triangle.
    [Show full text]
  • PUBERTY: MY CHANGING BODY Lesson 2
    PUBERTY: MY CHANGING DIFFERING ABILITIES BODY Lesson 2 LEARNER OUTCOME Identify, label and discuss human reproductive body parts. MATERIALS: 1. Public Parts Illustrations (unlabelled &labelled) 2. Private Parts Illustrations (unlabelled & labelled) 3. Whole Body Including Public and Private Parts Illustration 4. Body Outlines 5. Male Reproductive Parts (unlabelled & labelled) 6. Female Reproductive Parts (unlabelled & labelled) 7. Female & Male Puberty Progression Illustrations INTRODUCTION : I t is important for students to identify the physical changes that will happen during puberty and to learn how to take care of their growing bodies. This lesson will help students to become familiar with the appropriate terms for reproductive body parts, a skill that can help students stay safe. Teaching students when to talk about body parts in conversation is an important concept as students learn about public versus private behaviours. APPROACHES/STRATEGIES: A. GROUND RULES Ensure ground rules are established before beginning this lesson. For classes that have already established ground rules, quickly reviewing them can promote a successful lesson. DA.201708 © 2017 teachingsexualhealth.ca 1 You should be prepared for giggles in your class. Try to Having Ground acknowledge students’ reactions to the subject by Rules in place can be saying that puberty and body parts can be difficult to a very successful way talk about and it’s ok to feel a bit uncomfortable. to facilitate a positive classroom B. ESTABLISHING LANDMARKS – TALKING environment. Click ABOUT PRIVATE BODY PARTS here for more information on how to 1. Get your students to feel for their hipbones. set up ground rules. 2. Explain that we are going to be talking about our bodies, the changes our bodies go through as we grow up and the names for our private body parts.
    [Show full text]
  • Evidence for the Ten Steps to Successful Breastfeeding
    WHO/CHD/98.9 DISTR.: GENERAL ORIGINAL: ENGLISH Evidence for the Ten Steps to Successful Breastfeeding DIVISION OF CHILD HEALTH AND DEVELOPMENT World Health Organization Geneva 1998 © World Health Organization 1998 This document is not a formal publication of the World Health Organization (WHO), and all rights are reserved by the Organization. The document may, however, be freely reviewed, abstracted, reproduced or translated, in part or in whole, but not for sale or for use in conjunction with commercial purposes. The designations employed and the presentation of the material in this document do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The views expressed in documents by named authors are solely the responsibility of those authors. Cover illustration adapted from a poster by permission of the Ministry of Health, Peru. Contents INTRODUCTION............................................................................................................................1 Methods used in the review Presentation of information The Ten Steps to Successful Breastfeeding 1. Step 1: Policies..................................................................................................................... 6 1.1 Criteria ........................................................................................................
    [Show full text]
  • Lactation and Appetite-Regulating Hormones: Increased Maternal Plasma Peptide YY Concentrations 3–6 Months Postpartum
    Downloaded from British Journal of Nutrition (2015), 114, 1203–1208 doi:10.1017/S0007114515002536 © The Authors 2015 https://www.cambridge.org/core Lactation and appetite-regulating hormones: increased maternal plasma peptide YY concentrations 3–6 months postpartum Greisa Vila1,*, Judith Hopfgartner1, Gabriele Grimm2, Sabina M. Baumgartner-Parzer1, . IP address: Alexandra Kautzky-Willer1, Martin Clodi1 and Anton Luger1 1Department of Internal Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna, 170.106.34.90 Vienna 1090, Austria 2Department of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna 1090, Austria – – – (Submitted 12 October 2014 Final revision received 27 May 2015 Accepted 11 June 2015 First published online 24 August 2015) , on 28 Sep 2021 at 07:22:14 Abstract Breast-feeding is associated with maternal hormonal and metabolic changes ensuring adequate milk production. In this study, we investigate the impact of breast-feeding on the profile of changes in maternal appetite-regulating hormones 3–6 months postpartum. Study participants were age- and BMI-matched lactating mothers (n 10), non-lactating mothers (n 9) and women without any history of pregnancy or breast-feeding in the previous 12 months (control group, n 10). During study sessions, young mothers breast-fed or bottle-fed their babies, and maternal blood , subject to the Cambridge Core terms of use, available at samples were collected at five time points during 90 min: before, during and after feeding the babies. Outcome parameters were plasma concentrations of ghrelin, peptide YY (PYY), leptin, adiponectin, prolactin, cortisol, insulin, glucose and lipid values. At baseline, circulating PYY concentrations were significantly increased in lactating mothers (100·3(SE 6·7) pg/ml) v.
    [Show full text]
  • Human Development: from Conception to Maturity Desenvolvimento Humano: Da Concepção À Maturidade
    Review Campinas, v. 20, e2016161, 2017 http://dx.doi.org/10.1590/1981-6723.16116 ISSN 1981-6723 on-line version Human development: from conception to maturity Desenvolvimento humano: da concepção à maturidade Valdemiro Carlos Sgarbieri1, Maria Teresa Bertoldo Pacheco2* 1 Universidade Estadual de Campinas (UNICAMP), Faculdade de Engenharia de Alimentos, Departamento de Alimentos e Nutrição, Campinas/SP - Brazil 2 Secretaria de Agricultura e Abastecimento do Estado de São Paulo (SAA), Agência Paulista de Tecnologia dos Agronegócios (APTA), Instituto de Tecnologia de Alimentos (ITAL), Centro de Ciência e Qualidade de Alimentos, Campinas/SP - Brazil *Corresponding Author Maria Teresa Bertoldo Pacheco, Secretaria de Agricultura e Abastecimento do Estado de São Paulo (SAA), Agência Paulista de Tecnologia dos Agronegócios (APTA), Instituto de Tecnologia de Alimentos (ITAL), Centro de Ciência e Qualidade de Alimentos, Avenida Brasil, 2880, Caixa Postal: 139, CEP: 13070-178, Campinas/SP - Brazil, e-mail: [email protected] Cite as: Human development: from conception to maturity. Braz. J. Food Technol., v. 20, e2016161, 2017. Received: Nov. 07, 2016; Approved: Jan. 13, 2017 Abstract The main objective of this review was to describe and emphasize the care that a woman must have in the period prior to pregnancy, as well as throughout pregnancy and after the birth of the baby, cares and duties that should continue to be followed by mother and child throughout the first years of the child’s life. Such cares are of nutritional, behavioral and lifestyle natures, and also involve the father and the whole family. Human development, from conception to maturity, consists of a critical and important period due to the multitude of intrinsic genetic and environmental factors that influence, positively or negatively, the person’s entire life.
    [Show full text]